12/16
01:07 pm
ctso
Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
Low
Report
Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
12/15
04:02 pm
ctso
Cytosorbents Corporation (CTSO) Discusses Progress in Blood-Purification Programs and DrugSorb-ATR's Regulatory Path Transcript [Seeking Alpha]
Low
Report
Cytosorbents Corporation (CTSO) Discusses Progress in Blood-Purification Programs and DrugSorb-ATR's Regulatory Path Transcript [Seeking Alpha]
12/10
07:38 am
ctso
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 [Yahoo! Finance]
High
Report
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025 [Yahoo! Finance]
12/10
07:00 am
ctso
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
High
Report
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
11/17
06:49 pm
ctso
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London [Yahoo! Finance]
Medium
Report
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London [Yahoo! Finance]
11/17
05:42 pm
ctso
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
Medium
Report
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
11/14
04:18 pm
ctso
Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
Low
Report
Cytosorbents (NASDAQ:CTSO) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $10.00 price target on the stock.
11/14
08:09 am
ctso
Cytosorbents (NASDAQ:CTSO) had its price target lowered by analysts at HC Wainwright from $1.00 to $0.75. They now have a "neutral" rating on the stock.
Medium
Report
Cytosorbents (NASDAQ:CTSO) had its price target lowered by analysts at HC Wainwright from $1.00 to $0.75. They now have a "neutral" rating on the stock.
11/13
07:23 pm
ctso
Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Cytosorbents Corporation (CTSO) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/13
07:23 pm
ctso
Cytosorbents outlines cash flow breakeven targets for Q1 2026 through workforce and cost restructuring [Seeking Alpha]
Medium
Report
Cytosorbents outlines cash flow breakeven targets for Q1 2026 through workforce and cost restructuring [Seeking Alpha]
11/12
07:38 pm
ctso
Cytosorbents Q3 Earnings Preview [Seeking Alpha]
Low
Report
Cytosorbents Q3 Earnings Preview [Seeking Alpha]
11/11
07:31 am
ctso
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London [Yahoo! Finance]
Low
Report
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London [Yahoo! Finance]
11/11
07:00 am
ctso
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
Low
Report
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
10/30
07:00 am
ctso
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
Low
Report
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
10/28
07:00 am
ctso
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
Low
Report
In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
9/29
07:16 am
ctso
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen [Yahoo! Finance]
Medium
Report
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen [Yahoo! Finance]
9/29
07:00 am
ctso
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
Low
Report
CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen